Imaging Agent Can Help Differentiate Between Amyloidosis Types

Imaging Agent Can Help Differentiate Between Amyloidosis Types

283304

Imaging Agent Can Help Differentiate Between Amyloidosis Types

AT-01, an imaging agent being developed by Attralus, can help to differentiate between transthyretin (ATTR) amyloidosis — which includes familial amyloid polyneuropathy (FAP) — and other forms of amyloidosis, new clinical trial data indicate. The findings were presented in a poster, “Detection of Systemic AL Amyloidosis and Differentiation of AL from Attr Using 124I-p5+14 PET Imaging,” at the 62nd Annual American Society of Hematology Annual Meeting and Exposition, held virtually in December. Amyloidosis is a…

You must be logged in to read/download the full post.